Page 52 - Krishna Kant

India's slowdown warriors

Five companies that have defied the gloom, and are set to do even better once the Indian growth story resumes

India Inc's global dreams: So near, yet so far

Many of India's top companies now rival their global peers in scale of operations, but remain pygmies on key financial parameters

Winner takes all

Sun Pharma is now India's largest drug maker and among the ten most valuable pharma companies globally

More cheer so far this earnings season

The net profit of Sensex companies is up 23% and 14 out of 18 companies having beaten the earnings estimates

Auto, pharma steal show from textiles and jewellery in export mkt

In last ten years automobile and pharma exports have grown at a CAGR of 30% and 22% respectively

GAIL surprises with 31% jump in profits on lower subsidies

Net sales zoom 28% to Rs 15,981 cr

Tatas now only half as small as PSUs

Over 10 years, Tata group companies' investment in fixed assets increases at 24% CAGR; non-banking & financial PSUs' rises at 10.8%

IT wings help early birds fly high

Net profit of 82 firms up 20.2%, but topline growth slows to 14.7% on muted show by manufacturing firms

Royalty bigger than dividends for MNCs

In five years, royalty payments have grown 31.1% yearly, much faster than rise in revenue and profit

As Modi wants tax reforms, data show direct tax-GDP growth link

The post-1991 economic boom was accompanied by a reduction in indirect taxes and rise in the share of direct taxes, and vice versa in the current slowing

IT exports and remittances no more enough to cover import bill

In last ten years, India's import bill grew at a CAGR of 23% against 20% growth in IT exports and dollar remittances during the period

PSU exchange-traded fund a weak bet for investors

Putting money in key PSUs a better option

Navy helps public sector shipyards beat slowdown

Barring one, three debt-free and sitting on large cash reserves

Better days ahead for India Inc

IT, pharma and auto likely to drive earnings growth in the third quarter; banking, oil & gas and capital goods to be a drag

One stock at a time

Markets lack the fuel for a broader rally but you can still make money in 2014, if you select the right stocks and hold on to these for some time

We can grab a much larger share of global generic drug market: Dilip Shanghvi

Interview with Founder & Managing Director Sun Pharmaceutical

Cyrus Mistry scores faster than Sensex

Tata group's market value is up 38% against the 9% rise in the Sensex in the past 12 months

Cyrus Mistry's to-fix list widens

Many investments failed to generate projected returns and hit the company

When you are not sure about market direction, buy quality: Anoop Bhaskar

Interview with Head Equity, UTI Asset Management

40% of dividend-paying firms have cash deficits

In all, 434 dividend-paying firms had negative free cash flows last year. The number would rise further if dividend outgo is taken into account